Quality of Life in Elderly Patients After Pancreatic Cancer Surgery
NCT ID: NCT06079229
Last Updated: 2024-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12 participants
OBSERVATIONAL
2023-11-06
2024-04-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Surgery is currently the only curative option available to patients, but it is not an option for many patients who already have metastatic or locally advanced cancer at the time of diagnosis. The main studies carried out on this type of intervention in the elderly focus on the surgical aspect, and the tolerability of such surgery is not well studied.
The aim of this study is to describe the impact of pancreatic surgery on the independence in daily activities and quality of life of patients aged over 70 with pancreatic cancer. These patients underwent surgery at Édouard Herriot Hospital (Hospices Civils de Lyon) since July 2021, and the assessment will be conducted through telephone questionnaires.
It is hypothesised that these patients will be able to maintain their independence in terms of daily activities.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic Cancer
NCT04667403
Management of Symptomatic Advanced Pancreatic Adenocarcinoma
NCT02979483
Safety and Efficacy of Irreversible Electroporation for Locally Advanced Pancreatic Cancer
NCT02898649
Evaluation of GEMCITEST in Patients With Pancreatic Cancer and Treated by Chemotherapy
NCT03599154
Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.
NCT02072616
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients over 70 undergoing pancreatic cancer surgery at the Édouard Herriot Hospital.
This is a non-comparative study, in which all subjects with histologically proven pancreatic cancer (all types) on biopsy or surgical specimen, operated on for this cancer (by cephalic duodenopancreatectomy or left pancreatectomy) at the Édouard Herriot Hospital since July 2021, aged 70 or older at the time of surgery, will be included in the same group.
Phone call
The only follow-up visit provided for in the protocol was a telephone contact 3 to 30 months after the patient's surgery. The rest of the data required for the study were obtained from the patient's medical records, collected in the course of routine practice.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phone call
The only follow-up visit provided for in the protocol was a telephone contact 3 to 30 months after the patient's surgery. The rest of the data required for the study were obtained from the patient's medical records, collected in the course of routine practice.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Operated on for this cancer (by cephalic duodenopancreatectomy or left pancreatectomy) at the Édouard Herriot Hospital since July 2021
* 70 years of age or older at the time of surgery.
Exclusion Criteria
* Patients under curatorship, guardianship or legal protection
* Patient unable to express non-opposition
* Patient unreachable after 4 attempted calls over 3 consecutive weeks
* Patient deceased at the time of the telephone call
* Persons deprived of their liberty by a judicial or administrative decision
* Persons under compulsory psychiatric care
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Byeul-A KIM, MD
Role: PRINCIPAL_INVESTIGATOR
Service de Gériatrie aigue, Hôpital Édouard Herriot, Hospices Civils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Gériatrie aigue, Hôpital Edouard Herriot, Hospices Civils de Lyon
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A01551-44
Identifier Type: OTHER
Identifier Source: secondary_id
69HCL23_0569
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.